|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 May 2016 |
|
Main ID: |
NCT02761941 |
|
Date of registration:
|
03/05/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Excessive Warfarin Anticoagulation - Causes and Consequences
EWA |
|
Scientific title:
|
Excessive Warfarin Anticoagulation - Causes and Consequences |
|
Date of first enrolment:
|
May 2016 |
|
Target sample size:
|
25000 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02761941 |
|
Study type:
|
Observational [Patient Registry] |
|
Study design:
|
Observational Model: Cohort
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Finland
| | | | | | | |
|
Contacts
|
|
Name:
|
Juhani Airaksinen, prof |
|
Address:
|
|
|
Telephone:
|
+35823131005 |
|
Email:
|
juhani.airaksinen@tyks.fi |
|
Affiliation:
|
|
|
|
Name:
|
Juhani Airaksinen, Professor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Turku University Hospital |
|
|
Name:
|
Tuija Vasankari, RN |
|
Address:
|
|
|
Telephone:
|
+358 2 3130900 |
|
Email:
|
tuija.vasankari@tyks.fi |
|
Affiliation:
|
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- VKA treatment, age > 18, INR >9,
Exclusion Criteria:
- age < 18
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Anticoagulation
|
|
Primary Outcome(s)
|
|
All cause mortality
[Time Frame: 90 days]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|